• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自身免疫与青光眼

Autoimmunity and glaucoma.

作者信息

Grus Franz H, Joachim Stephanie C, Wuenschig Diana, Rieck Jochen, Pfeiffer Norbert

机构信息

Experimental Ophthalmology, Department of Ophthalmology, Johannes Gutenberg University, Mainz, Germany.

出版信息

J Glaucoma. 2008 Jan-Feb;17(1):79-84. doi: 10.1097/IJG.0b013e318156a592.

DOI:10.1097/IJG.0b013e318156a592
PMID:18303391
Abstract

Elevated intraocular pressure does not explain glaucoma in all patients, but there is information that autoimmune mechanisms may be involved in this disorder. This review attempts to reveal the findings about specific changes in autoantibody profiles in glaucoma patients and their possible role in glaucoma. Considering that these changes in natural autoimmunity can be found consistently among different study populations, it might be a promising new tool for glaucoma detection.

摘要

眼压升高并不能解释所有患者的青光眼病因,但有信息表明自身免疫机制可能参与了这种疾病。本综述试图揭示青光眼患者自身抗体谱的特定变化及其在青光眼中可能的作用。鉴于在不同研究人群中均可一致发现这些自然自身免疫的变化,它可能成为一种有前景的青光眼检测新工具。

相似文献

1
Autoimmunity and glaucoma.自身免疫与青光眼
J Glaucoma. 2008 Jan-Feb;17(1):79-84. doi: 10.1097/IJG.0b013e318156a592.
2
[Relationship between oxidatve stress and autoimmunity in glaucoma].[青光眼氧化应激与自身免疫的关系]
Klin Monbl Augenheilkd. 2010 Feb;227(2):114-9. doi: 10.1055/s-0029-1245150. Epub 2010 Feb 12.
3
The case for autoimmunity in glaucoma.青光眼自身免疫的病例。
Exp Eye Res. 2011 Aug;93(2):187-90. doi: 10.1016/j.exer.2010.08.016. Epub 2010 Aug 27.
4
Immunological mechanisms in glaucoma.青光眼的免疫机制
Semin Immunopathol. 2008 Apr;30(2):121-6. doi: 10.1007/s00281-008-0105-8. Epub 2008 Mar 11.
5
Complex antibody profile changes in an experimental autoimmune glaucoma animal model.实验性自身免疫性青光眼动物模型中的复杂抗体谱变化
Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4734-42. doi: 10.1167/iovs.08-3144. Epub 2009 May 20.
6
Does autoimmunity play a part in the pathogenesis of glaucoma?自身免疫在青光眼发病机制中起作用吗?
Prog Retin Eye Res. 2013 Sep;36:199-216. doi: 10.1016/j.preteyeres.2013.02.003. Epub 2013 Mar 27.
7
Autoimmune basis of glaucoma.青光眼的自身免疫基础
Semin Ophthalmol. 2011 Jul-Sep;26(4-5):278-81. doi: 10.3109/08820538.2011.588649.
8
The pathogenesis of glaucoma in the interplay with the immune system.青光眼在与免疫系统相互作用中的发病机制。
Invest Ophthalmol Vis Sci. 2013 Mar 28;54(3):2393-409. doi: 10.1167/iovs.12-9781.
9
[Autoimmunity and glaucoma].[自身免疫与青光眼]
Klin Monbl Augenheilkd. 2011 May;228(5):439-45. doi: 10.1055/s-0031-1273355. Epub 2011 Apr 29.
10
Autoimmune biomarkers in glaucoma patients.青光眼患者的自身免疫生物标志物。
Curr Opin Pharmacol. 2013 Feb;13(1):90-7. doi: 10.1016/j.coph.2012.09.005. Epub 2012 Sep 30.

引用本文的文献

1
Rho Kinase (ROCK) Inhibitors in the Treatment of Glaucoma and Glaucoma Surgery: A Systematic Review of Early to Late Phase Clinical Trials.Rho激酶(ROCK)抑制剂在青光眼及青光眼手术治疗中的应用:早期至晚期临床试验的系统评价
Pharmaceuticals (Basel). 2025 Apr 3;18(4):523. doi: 10.3390/ph18040523.
2
Exploring the Ocular Surface Microbiome and Tear Proteome in Glaucoma.探索青光眼的眼表微生物组和泪液蛋白质组。
Int J Mol Sci. 2024 Jun 6;25(11):6257. doi: 10.3390/ijms25116257.
3
Neuroretinal Cell Culture Model as a Tool for the Development of New Therapeutic Approaches for Oxidative Stress-Induced Ocular Diseases, with a Focus on Glaucoma.
神经视网膜细胞培养模型作为一种开发氧化应激诱导的眼部疾病(重点是青光眼)新治疗方法的工具。
Cells. 2024 May 1;13(9):775. doi: 10.3390/cells13090775.
4
Synthesis, Characterization, and Evaluation of a Novel Potent Autotaxin-Inhibitor.一种新型强效自分泌运动因子抑制剂的合成、表征及评估
Front Pharmacol. 2022 Jan 18;12:699535. doi: 10.3389/fphar.2021.699535. eCollection 2021.
5
Proteomic Analysis of Retinal Tissue in an S100B Autoimmune Glaucoma Model.S100B自身免疫性青光眼模型中视网膜组织的蛋白质组学分析。
Biology (Basel). 2021 Dec 23;11(1):16. doi: 10.3390/biology11010016.
6
Therapeutic Drugs and Devices for Tackling Ocular Hypertension and Glaucoma, and Need for Neuroprotection and Cytoprotective Therapies.治疗高眼压症和青光眼的治疗药物与设备,以及神经保护和细胞保护疗法的必要性。
Front Pharmacol. 2021 Sep 17;12:729249. doi: 10.3389/fphar.2021.729249. eCollection 2021.
7
Can the Treatment of Normal-Pressure Hydrocephalus Induce Normal-Tension Glaucoma? A Narrative Review of a Current Knowledge.正常压力脑积水的治疗会诱发正常眼压性青光眼吗?当前知识的叙述性综述
Medicina (Kaunas). 2021 Mar 3;57(3):234. doi: 10.3390/medicina57030234.
8
Neuroinflammation in Primary Open-Angle Glaucoma.原发性开角型青光眼的神经炎症
J Clin Med. 2020 Sep 30;9(10):3172. doi: 10.3390/jcm9103172.
9
Synapse and Receptor Alterations in Two Different S100B-Induced Glaucoma-Like Models.两种不同 S100B 诱导的青光眼样模型中的突触和受体改变。
Int J Mol Sci. 2020 Sep 23;21(19):6998. doi: 10.3390/ijms21196998.
10
Preservation of optic nerve structure by complement inhibition in experimental glaucoma.实验性青光眼通过补体抑制保护视神经结构。
Cell Tissue Res. 2020 Nov;382(2):293-306. doi: 10.1007/s00441-020-03240-7. Epub 2020 Jul 17.